Variability in lipid profile before and after coronary artery bypass grafting (CABG)

Journal of the Pakistan Medical Association

Volumn 55, Issue 3, 2005, Pages 95-98

  Iqbal, M Perwaiz ^a   Sharif, Hasanat Mohammad ^a   Mehboobali, Naseema ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MALE; MORTALITY; PAKISTAN; PREOPERATIVE PERIOD; UNIVERSITY HOSPITAL;

AGED; ANGINA PECTORIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY BYPASS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PAKISTAN; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; REFERENCE VALUES; RISK FACTORS; TRIGLYCERIDES;

EID: 17644407759     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Blankenhorn DH, Brooks SH, Selzer RH, Brandt R. The rate of atherosclerosis change during treatment of hyperlipoproteinemia. Circulation 1978;57:355-61.
2. Nash DT, Gensini G, Esente P. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography. Int J Cardiol 1982;2;43-55.
3. Ooi M, Cooper A, Lloyol G, Jackson G. A study of lipid profile before and after coronary artery bypass grafting. Br J Clin Pract 1996;50:433-5.
4. Novaro GM, Pearce GL, Sprecher DL, Griffin BP. Comparison of cardiovascular risk and lipid profiles and patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis 2001;10:19-24.
5. McKeigue PM, Marmot MG. Mortality from coronary heart disease in Asian communities in London. BMJ 1988;297:903.
6. Iqbal MP, Shafiq M, Mehboobali N. Variability in lipid profile in Pakistani patients with acute myocardial infarction. J Pak Med Assoc 2004;54:544-9.
7. Foody JM, Ferdinand FD, Pearce GL, Lytle BW, Cosgrove DM, Sprecher DL. HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from the Cleveland Clinic Foundation. Circulation 2000;102 (19 Suppl. 3):11190-4.
8. Sprecher DL, Pearce GL, Cosgrove DM, Lytle BW, Loop FD, Pashkow FJ. Relation of serum triglyceride levels to survival after coronary artery bypass grafting. Am J Cardiol 2000;86:285-8.
9. Figueroa O, Franco-Saenz R, Mulrow PG. Changes in cholesterol levels after coronary artery bypass surgery. Am J Med Sci 1992;303:73-7.
10. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-97.
11. Shaukat N, Ashraf SS, Mackness MI. A prospective study of serum lipoproteins after coronary artery bypass surgery. QJM 1994;87:539-45.
12. Passamani ER. Cholesterol reduction in coronary artery bypass patients. JAMA 1987;257:3271-2.
13. Virk Z, Khan AA, Bokhari AM. Ischemic heart disease in the young population (35 years) a clinical profile. Pak J Cardiol 1995;6:64-6.
14. Choudhury L, Marsh J. Myocardial infarction in young patients. Am J Med 1999;107:254-61
15. Krishnaswarmi S, Prasad N, Jose VJ. A study of lipid levels in Indian patients with coronary heart disease. Int J Cardiol 1989;24:337-45.
16. Pais P, Pogue J, Gerstein H, Zachariah E, Saritha D, Jayprakash S. Risk factor for acute myocardial infarction in Indians: A case-control study. Lancet 1996;348:358-63.
17. Goldsmith I, Lip GY, Emsden K, Nugent A, Patel RL. Hyperlipidemia management after primary coronary artery bypass surgery: a survey of patients and practitioners. J Cardiovasc Risk 1999;6:263-7.
18. Iqbal MP, Shafiq M, Mehboobali N. Hypertriglyceridemia and low HDL-cholesterol are the major lipid abnormalities in normal Pakistani adults: are these contributing to the high rates of coronary artery disease in the population? Pak J Med Sci 2004;20:385-91.
19. Batiste MC, Schaefer EJ. Diagnosis and management of lipoprotein abnormalities. Nutr Clin Care 2002;5:115-23.
20. Sampson P Quit smoking - or suffer low blood HDL levels. JAMA 1978;239:690-2.
21. Huttunen JK, Länsimies E, Voutilainen E, Ehnholm C, Hietanen E, Pentilla I. Effect of moderate physical exercise on serum lipoproteins: A controlled clinical trial with special reference to serum high density lipoproteins. Circulation 1979;60:1220-9.
22. Rackley CE. Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease. Clin Cardiol 1996;19:683-9.